BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 27191675)

  • 41. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
    Kang JJ; de la Cruz J; Cortina MS
    Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Boston keratoprosthesis: 73 eyes from Germany : An overview of experiences from two centers].
    Schaub F; Neuhann I; Enders P; Bachmann BO; Koller B; Neuhann T; Cursiefen C
    Ophthalmologe; 2018 Sep; 115(9):744-753. PubMed ID: 29043440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Donor Corneal Transplantation vs Boston Type 1 Keratoprosthesis in Patients with Previous Graft Failures: A Retrospective Single Center Study (An American Ophthalmological Society Thesis).
    Akpek EK; Cassard SD; Dunlap K; Hahn S; Ramulu PY
    Trans Am Ophthalmol Soc; 2015; 113():T3. PubMed ID: 26538773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative Outcomes of Boston Keratoprosthesis Type 1 Implantation Based on Vision in the Contralateral Eye.
    Shanbhag SS; Saeed HN; Colby KA; Chodosh J
    Cornea; 2018 Nov; 37(11):1408-1413. PubMed ID: 30179893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
    Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
    Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Boston keratoprosthesis in herpetic keratitis.
    Khan BF; Harissi-Dagher M; Pavan-Langston D; Aquavella JV; Dohlman CH
    Arch Ophthalmol; 2007 Jun; 125(6):745-9. PubMed ID: 17562983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Russian Keratoprosthesis in Stevens-Johnson Syndrome.
    Ma X; Xiang R; Meng X; Qin L; Wu Y; Tain L; Jiang Y; Huang Y; Wang L
    Cornea; 2017 Mar; 36(3):304-309. PubMed ID: 27941382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal.
    Hassanaly SI; Talajic JC; Harissi-Dagher M
    Am J Ophthalmol; 2014 Aug; 158(2):270-276.e1. PubMed ID: 24844976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
    Zerbe BL; Belin MW; Ciolino JB;
    Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Boston keratoprosthesis outcomes and complications.
    Chew HF; Ayres BD; Hammersmith KM; Rapuano CJ; Laibson PR; Myers JS; Jin YP; Cohen EJ
    Cornea; 2009 Oct; 28(9):989-96. PubMed ID: 19724214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Long-term outcomes of Boston keratoprosthesis].
    Mori Y; Nejima R; Minami K; Miyata K; Kamiya K; Fukud M
    Nippon Ganka Gakkai Zasshi; 2013 Jan; 117(1):35-43. PubMed ID: 23424974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Boston keratoprosthesis type I in mucous membrane pemphigoid.
    Palioura S; Kim B; Dohlman CH; Chodosh J
    Cornea; 2013 Jul; 32(7):956-61. PubMed ID: 23538625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
    Verdejo-Gómez L; Peláez N; Gris O; Güell JL
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):446-52. PubMed ID: 21919432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety of Concurrent Boston Type I Keratoprosthesis and Glaucoma Drainage Device Implantation.
    Lenis TL; Chiu SY; Law SK; Yu F; Aldave AJ
    Ophthalmology; 2017 Jan; 124(1):12-19. PubMed ID: 27614591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Boston Type 1 Keratoprosthesis for Gelatinous Drop-Like Corneal Dystrophy.
    Lekhanont K; Jongkhajornpong P; Chuephanich P; Inatomi T; Kinoshita S
    Optom Vis Sci; 2016 Jun; 93(6):640-6. PubMed ID: 26990741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis.
    Li JY; Greiner MA; Brandt JD; Lim MC; Mannis MJ
    Am J Ophthalmol; 2011 Aug; 152(2):209-18. PubMed ID: 21636070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation.
    Dunlap K; Chak G; Aquavella JV; Myrowitz E; Utine CA; Akpek E
    Ophthalmology; 2010 Apr; 117(4):687-92. PubMed ID: 20096462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Boston Keratoprosthesis Outcomes in Severe Ocular Chemical Burns in Southern China: A Retrospective Study.
    Gu J; Zhai J; Zhou S; Chen J
    Adv Ther; 2016 May; 33(5):760-73. PubMed ID: 27126407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis.
    Goldman DR; Hubschman JP; Aldave AJ; Chiang A; Huang JS; Bourges JL; Schwartz SD
    Retina; 2013 Mar; 33(3):532-41. PubMed ID: 23073339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.